• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

瑞德西韦在南非的作用：通过增加重症监护病房容量来预防 COVID-19 死亡。

The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity.

机构信息

Department of Global Health, School of Public Health, Boston University, Boston, Massachusetts, USA.

Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

出版信息

Clin Infect Dis. 2021 May 4;72(9):1642-1644. doi: 10.1093/cid/ciaa937.

DOI:10.1093/cid/ciaa937
PMID:32628744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7454458/
Abstract

Countries such as South Africa have limited intensive care unit (ICU) capacity to handle the expected number of patients with COVID-19 requiring ICU care. Remdesivir can prevent deaths in countries such as South Africa by decreasing the number of days people spend in ICU, therefore freeing up ICU bed capacity.

摘要

南非等国的重症监护病房（ICU）能力有限，无法应对预计需要 ICU 护理的 COVID-19 患者数量。瑞德西韦可以通过减少人们在 ICU 中度过的天数，从而腾出 ICU 床位，来预防南非等国的死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c88b/8096260/00e90604530a/ciaa937f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c88b/8096260/00e90604530a/ciaa937f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c88b/8096260/00e90604530a/ciaa937f0001.jpg

相似文献

1
The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity.瑞德西韦在南非的作用：通过增加重症监护病房容量来预防 COVID-19 死亡。
Clin Infect Dis. 2021 May 4;72(9):1642-1644. doi: 10.1093/cid/ciaa937.
2
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.同情使用瑞德西韦治疗重症监护病房（ICU）和非 ICU 患者的严重新冠肺炎肺炎：临床结局和治疗后住院状况的差异。
Pharmacol Res. 2020 Aug;158:104899. doi: 10.1016/j.phrs.2020.104899. Epub 2020 May 11.
3
Comment on: Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU.关于《瑞德西韦对意大利重症监护病房中接受机械通气的新冠肺炎患者的疗效》的评论
J Antimicrob Chemother. 2021 May 12;76(6):1650-1651. doi: 10.1093/jac/dkab033.
4
Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact.瑞德西韦和地塞米松缓解 COVID-19 导致的医院护理系统压力的工具：床位资源和预算影响的建模研究。
PLoS One. 2022 Jan 12;17(1):e0262462. doi: 10.1371/journal.pone.0262462. eCollection 2022.
5
Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU-authors' response.瑞德西韦对意大利重症监护病房中接受机械通气的COVID-19患者的疗效——作者回应
J Antimicrob Chemother. 2021 May 12;76(6):1651-1652. doi: 10.1093/jac/dkab092.
6
Early Administration of Remdesivir and Intensive Care Unit Admission in Hospitalized Pregnant Individuals With Coronavirus Disease 2019 (COVID-19).《COVID-19 住院孕妇中瑞德西韦的早期应用和入住重症监护病房》
Obstet Gynecol. 2022 Apr 1;139(4):619-621. doi: 10.1097/AOG.0000000000004734. Epub 2022 Feb 4.
7
Estimation Model for Healthcare Costs and Intensive Care Units Access for Covid-19 Patients and Evaluation of the Effects of Remdesivir in the Portuguese Context: Hypothetical Study.Covid-19 患者医疗费用和重症监护病房使用的估算模型及在葡萄牙环境下评估瑞德西韦效果的研究：假设研究。
Clin Drug Investig. 2022 Apr;42(4):345-354. doi: 10.1007/s40261-022-01128-8. Epub 2022 Mar 17.
8
Clinical Efficacy and Safety of Remdesivir among Hospitalised Adult Patients with RT PCR Confirmed COVID 19 Requiring ICU Care in Kalyana Karnataka.卡纳塔克邦卡拉亚纳住院的 COVID 19 成年患者，需要 ICU 护理，瑞德西韦的临床疗效和安全性：RT PCR 确诊。
J Assoc Physicians India. 2021 Aug;69(8):11-12.
9
Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.瑞德西韦治疗重症新型冠状病毒肺炎：一家社区医院的经验
J Am Osteopath Assoc. 2020 Dec 1;120(12):926-933. doi: 10.7556/jaoa.2020.156.
10
Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.瑞德西韦治疗与 COVID-19 住院美国退伍军人的生存和住院时间的关系。
JAMA Netw Open. 2021 Jul 1;4(7):e2114741. doi: 10.1001/jamanetworkopen.2021.14741.

引用本文的文献

1
Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources.美国住院COVID-19患者使用瑞德西韦：医疗资源优化
Infect Dis Ther. 2023 Jun;12(6):1655-1665. doi: 10.1007/s40121-023-00816-y. Epub 2023 May 24.
2
The National COVID-19 Epi Model (NCEM): Estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa.国家新冠疫情流行病学模型（NCEM）：估算南非第一波新冠疫情的病例数、住院人数和死亡人数。
PLOS Glob Public Health. 2023 Apr 24;3(4):e0001070. doi: 10.1371/journal.pgph.0001070. eCollection 2023.
3
Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review.

本文引用的文献

1
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.瑞德西韦治疗新冠病毒病-初步报告。回复。
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
2
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区，5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
3
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
瑞德西韦治疗 COVID-19 的成本效益及成本与资源使用证据：系统评价。
Infection. 2023 Apr;51(2):285-303. doi: 10.1007/s15010-022-01930-8. Epub 2022 Oct 12.
4
Dental Healthcare Amid the COVID-19 Pandemic.COVID-19 大流行期间的牙科医疗保健。
Int J Environ Res Public Health. 2021 Oct 20;18(21):11008. doi: 10.3390/ijerph182111008.
5
Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey.瑞德西韦治疗需要低流量氧疗的 COVID-19 患者的成本效益分析：土耳其支付者视角。
Adv Ther. 2021 Sep;38(9):4935-4948. doi: 10.1007/s12325-021-01874-9. Epub 2021 Aug 11.
6
Characteristics, management and outcomes of critically ill COVID-19 patients admitted to ICU in hospitals in Bangladesh: a retrospective study.孟加拉国医院重症监护病房收治的危重症 COVID-19 患者的特征、管理及结局：一项回顾性研究
J Prev Med Hyg. 2021 Apr 29;62(1):E33-E45. doi: 10.15167/2421-4248/jpmh2021.62.1.1838. eCollection 2021 Mar.
7
Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa.瑞德西韦和地塞米松用于南非COVID-19治疗的成本效益
Open Forum Infect Dis. 2021 Jan 29;8(3):ofab040. doi: 10.1093/ofid/ofab040. eCollection 2021 Mar.
8
The COVID-19 Treatment Landscape: A South African Perspective on a Race Against Time.新冠疫情治疗全景：南非视角下与时间的赛跑
Front Med (Lausanne). 2021 Feb 19;8:604087. doi: 10.3389/fmed.2021.604087. eCollection 2021.
9
Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review.HIV 相关子痫前期合并 COVID-19 孕妇的血管内皮功能障碍：综述。
Hypertens Res. 2021 Apr;44(4):386-398. doi: 10.1038/s41440-020-00604-y. Epub 2021 Jan 20.
10
COVID-19, disability and the context of healthcare triage in South Africa: Notes in a time of pandemic.新冠疫情、残疾与南非医疗分诊背景：大流行时期的笔记
Afr J Disabil. 2020 Aug 18;9:766. doi: 10.4102/ajod.v9i0.766. eCollection 2020.
中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
4
An evaluation of inpatient morbidity and critical care provision in Zambia.赞比亚住院患者发病率和重症监护服务评估。
Anaesthesia. 2017 Feb;72(2):172-180. doi: 10.1111/anae.13709. Epub 2016 Nov 21.